Cognetivity Neurosciences Ltd

Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimers disease. Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis

Artificial intelligence,medical devices,diagnostics,health monitoring,samd,digital health,cognitive assessment,neuroscience,dementia,technology,diagnosis,and alzheimer's disease

Cognetivity neurosciences ltd operates in the Health, wellness & fitness industry.

Cognetivity neurosciences ltd's revenue is 11m - 100m

Cognetivity neurosciences ltd has 11 - 50 employees.